Monday, 09 Dec 2019

You are here

The RheumNow Week in Review – 9 June 2017

Dr. Jack Cush reviews the news and reports of interest from RheumNow in the last week:

  1. Abbvie Scholarship program accepting applications to award 15 grants ($15k/yr) to Students with Rheumatic disorders https://t.co/lgDLQRznJN
  2. Using Claims data, Allopurinol associated with lower risk of incident renal disease (HR 0.61) compared to febuxostat https://t.co/iGUKB4MxK0
  3. SLE myositis more likely to have rash, alopecia, pericarditis, vasculitis, Sm, RNP, dsDNA, low Plts & WBC, low C3.C4 https://t.co/UwWVr1XuhY
  4. Autoimmune diseases w/ MYOCARDITIS include sarcoidosis, Behçets, Churg-Strauss, inflammatory myositis, SLE https://t.co/zb3LdzUL9G
  5. QUEST-RA study shows the average RA pt has 2+ comorbidities (HTN, OP,OA); fatigue assoc w/ comorbidity & dz activity https://t.co/BPTsGW82ho
  6. Retro review of open label Tofacitinib 5 mg bid in 13 pts w/ alopecia areata showing ~50% regrowth after 4-5 mos https://t.co/Umw6vCOp3j
  7. Case reports showing tofacitinib, ruloxocitinb efficacy in difficult dermatomyositis, leads makers of JAK inhibitors to consider RCTs in DM
  8. Metormins effx mediated by change in gut microbiome; transfer of metformin-altered microbiota improves Glu tolerance https://t.co/1HvCnS19kW
  9. FDA Requests Removal of OPANA-ER from the Market 
  10. Debate over Alcohol and Methotrexate Precautions 
  11. Biosimilar Reports – May 2017
  12. Higher Fracture Risks with Prolonged Bisphosphonate Use in Older Women

 

 

 

Disclosures: 
The author has received compensation as an advisor or consultant on this subject

Add new comment

More Like This

RheumNow Podcast - Monitoring Methotrexate Safety (12-6-19)

Dr. Jack Cush reviews the news and journal reports from the past week on RheumNow.com.

#WomenInRheumatology: Is There a Speaker Gender Gap at ACR Meetings?

Recent studies have quantified the gender gap among speakers at academic conferences. The largest study of 181 medical conferences held in North America over one decade found an increase in the proportion of female speakers from 25 to 34% over time, and that the underrepresentation of women was more marked at surgical compared to medical conferences.

RheumNow Podcast –Favorites of ACR 2019 (11.22.19)

Dr. Jack Cush recaps standout presentations and information from ACR 2019 held in Atlanta November 9-12, 2019.

Hepatitis C-Related Cryoglobulinemic Vasculitis

Flares of vasculitis can still be a problem after hepatitis C-related cryoglobulinemic vasculitis patients are cured of their hepatitis C by direct-acting antivirals, as demonstrated by data from four registries presented at ACR 2019 in Atlanta, Georgia.

ACR 2019 - Report from Day One (Sunday)

Sunday was the first full day of scientific sessions at the 2019 ACR/ARP meeting in Atlanta. Yesterday we shared our initial news articles, videos and more with you. Following is my roundup of day one. 

Delays in Diagnosis